Correction of acute liver cell failure disorders through liver xenoperfusion: experimental study.
Adham
M
M
Department of Surgery, Hôpital de la Croix Rousse, Lyon, France.
Sab
J M
JM
Ducerf
C
C
Tassaux
D
D
Vianey-Saban
C
C
Chevallier
M
M
de la Roche
E
E
Le
Q V
QV
Bizollon
T
T
Barakat
C
C
Debize
G
G
Vernet
M
M
Pouyet
M
M
Baulieux
J
J
D000328:Adult; D000596:Amino Acids / Q000097:blood; D000818:Animals; D000910:Antibodies, Heterophile / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001779:Blood Coagulation Factors / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis*; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D017114:Liver Failure, Acute / Q000097:blood* / Q000628:therapy*; D010477:Perfusion / Q000379:methods*; D010951:Plasma Exchange; D013552:Swine; D014183:Transplantation, Heterologous
D000596:Amino Acids; D000910:Antibodies, Heterophile; D001779:Blood Coagulation Factors; D001798:Blood Proteins; D003176:Complement C3; D003181:Complement C4; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D001663:Bilirubin